New Delhi: More than 136 Doses of Covid-19 Crore Vaccine is expected to be available until the end of this year, notify the center.
For the next four months, the Indian vaccine program will be accelerated by the Serum Institute (SII) Covishield and Bharat Biotech Covaxin.
Note titled “Covid-19 Public Health Response Pro-active, pre-emptive and assess the guided response by epidemiology and scientific rigor” also provides details about the vaccine production target given to parliamentarians from the Prime Minister’s office (PMO).
According to the record, “In August the projection of the Covaxin vaccine will be 2.65 crores, the Covishield will be 23 crores and the total dose of 25.65 crores will be produced in the month.
In September the Covaxin projection is 3.15 crores and covishield will be 23 crores.
, which will totally be 26.15 Crore doses.
In October a total of 28.25 doses of crore will be generated from which Covaxin will be 5.25 crores and covishield will be 23 doses of crore.
“In addition, 28.25 Crore doses will be available In November 5,25 crores would be in the form of covaxin and 23 crore covishield.
In December, the Covaxin projection will be 5.25 crores and covishield will be 23 doses of crore, which will total will be 28.5 doses of crore for the month.
In accordance with the order of progress placed by the center for August to December 2021, 75 percent of the covishield vaccine dose will be purchased at Rs 215.25 per dose with a total cost of Rs 8,071.87 Crore.
This note also mentions the government will buy 28.5 doses of Crore Covaxin from Bharat Biotech at Rs 225.75 per dose at a cost of Rs 6,433.87 Crore.
In Sputnik V production, the record said, “Sputnik V has not been produced until July and is expected to be produced 25 million doses in August, September and October by Panacea.
After that there is no clarity / visibility because it depends on the mass to be provided by Russia To fill out.
So, the total production for this year can be expected by 2044.16 million doses.
“The Ministry of Health Union provides a presentation to parliamentarians about the Covid situation in the country and actions taken during the crisis.
“Because of the ongoing field activities in terms of increasing testing, supervision, clinical management, and other activities for more than a year, the health system witnesses fatigue,” he said.
Note has also stated, “Human resources crunch experienced during the second wave due to lack of doctors and health care workers in all urban areas.” “The lack of behavior in accordance with Covid and satisfied in the community during open economic activities, the virus spreads rapidly throughout India,” he said.
“With a surge in unexpected cases, challenges in terms of infrastructure augmentation throughout the country, an increase in oxygen supply, the needs of drugs and other logistics appear,” he added.
Furthermore, the note mentions the management of medical oxygen and drug management during the second wave.